NCT03893487 2025-07-11PNOC016University of California, San FranciscoPhase EARLY_PHASE1 Active not recruiting30 enrolled
NCT05971758 2025-07-04Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing DiseaseUniversity of California, Los AngelesPhase 2 Recruiting20 enrolled